Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics

Abstract The present study was aimed at revealing the metabolic changes that occurred in the cellular lipid pattern of acute and chronic myeloid leukaemia cells following treatment with cannabidiol (CBD). CBD is a non-psychoactive compound present in Cannabis sativa L., which has shown an antiprolif...

Full description

Saved in:
Bibliographic Details
Main Authors: David Chamoso-Sanchez, Martina Panini, Clarissa Caroli, Matilde Marani, Lorenzo Corsi, Francisco J Rupérez, Antonia Garcia, Federica Pellati
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86044-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594743115120640
author David Chamoso-Sanchez
Martina Panini
Clarissa Caroli
Matilde Marani
Lorenzo Corsi
Francisco J Rupérez
Antonia Garcia
Federica Pellati
author_facet David Chamoso-Sanchez
Martina Panini
Clarissa Caroli
Matilde Marani
Lorenzo Corsi
Francisco J Rupérez
Antonia Garcia
Federica Pellati
author_sort David Chamoso-Sanchez
collection DOAJ
description Abstract The present study was aimed at revealing the metabolic changes that occurred in the cellular lipid pattern of acute and chronic myeloid leukaemia cells following treatment with cannabidiol (CBD). CBD is a non-psychoactive compound present in Cannabis sativa L., which has shown an antiproliferative action in these type of cancer cells. CBD treatment reduced cell viability and initiated apoptotic and necrotic processes in both cancer cell lines in a time and dose-dependent manner, showing acute myeloid leukaemia (HL-60) cells greater sensitivity than chronic myeloid leukaemia ones (K-562), without differences in the activation of caspases 3/7. Then, control and treated cells of HL-60 and K-562 cell lines were studied through an untargeted lipidomic approach. The treatment was carried out with CBD at a concentration of 10 μM for HL-60 cells and 23 µM CBD for K-562 cells for 48 h. After the extraction of the lipid content from cell lysates, the samples were analysed by UHPLC-QTOF-MS/MS both in the positive and the negative ionization modes. The comprehensive characterization of cellular lipids unveiled several classes significantly affected by CBD treatment. Most of the differences correspond to phospholipids, including cardiolipins (CL), phosphatidylcholines (PC) and phosphosphingolipids (SM), and also triacylglycerols (TG), being many TG species increased after CBD treatment in the acute and chronic models, whereas phospholipids were found to be decreased. The results highlight some important lipid alterations related to CBD treatment, plausibly connected with different metabolic mechanisms involved in the process of cell death by apoptosis in cancer cell lines.
format Article
id doaj-art-15e46fa1c2b54a2d8d283b56654b857b
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-15e46fa1c2b54a2d8d283b56654b857b2025-01-19T12:21:18ZengNature PortfolioScientific Reports2045-23222025-01-0115111410.1038/s41598-025-86044-5Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomicsDavid Chamoso-Sanchez0Martina Panini1Clarissa Caroli2Matilde Marani3Lorenzo Corsi4Francisco J Rupérez5Antonia Garcia6Federica Pellati7Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización MontepríncipeDepartment of Life Sciences, University of Modena and Reggio EmiliaDepartment of Life Sciences, University of Modena and Reggio EmiliaDepartment of Life Sciences, University of Modena and Reggio EmiliaDepartment of Life Sciences, University of Modena and Reggio EmiliaCentro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización MontepríncipeCentro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización MontepríncipeDepartment of Life Sciences, University of Modena and Reggio EmiliaAbstract The present study was aimed at revealing the metabolic changes that occurred in the cellular lipid pattern of acute and chronic myeloid leukaemia cells following treatment with cannabidiol (CBD). CBD is a non-psychoactive compound present in Cannabis sativa L., which has shown an antiproliferative action in these type of cancer cells. CBD treatment reduced cell viability and initiated apoptotic and necrotic processes in both cancer cell lines in a time and dose-dependent manner, showing acute myeloid leukaemia (HL-60) cells greater sensitivity than chronic myeloid leukaemia ones (K-562), without differences in the activation of caspases 3/7. Then, control and treated cells of HL-60 and K-562 cell lines were studied through an untargeted lipidomic approach. The treatment was carried out with CBD at a concentration of 10 μM for HL-60 cells and 23 µM CBD for K-562 cells for 48 h. After the extraction of the lipid content from cell lysates, the samples were analysed by UHPLC-QTOF-MS/MS both in the positive and the negative ionization modes. The comprehensive characterization of cellular lipids unveiled several classes significantly affected by CBD treatment. Most of the differences correspond to phospholipids, including cardiolipins (CL), phosphatidylcholines (PC) and phosphosphingolipids (SM), and also triacylglycerols (TG), being many TG species increased after CBD treatment in the acute and chronic models, whereas phospholipids were found to be decreased. The results highlight some important lipid alterations related to CBD treatment, plausibly connected with different metabolic mechanisms involved in the process of cell death by apoptosis in cancer cell lines.https://doi.org/10.1038/s41598-025-86044-5CannabidiolLeukaemiaCancer cellsApoptosisLipidomicsUHPLC-MS/MS
spellingShingle David Chamoso-Sanchez
Martina Panini
Clarissa Caroli
Matilde Marani
Lorenzo Corsi
Francisco J Rupérez
Antonia Garcia
Federica Pellati
Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
Scientific Reports
Cannabidiol
Leukaemia
Cancer cells
Apoptosis
Lipidomics
UHPLC-MS/MS
title Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
title_full Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
title_fullStr Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
title_full_unstemmed Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
title_short Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
title_sort unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
topic Cannabidiol
Leukaemia
Cancer cells
Apoptosis
Lipidomics
UHPLC-MS/MS
url https://doi.org/10.1038/s41598-025-86044-5
work_keys_str_mv AT davidchamososanchez unveilingcellularchangesinleukaemiacelllinesaftercannabidioltreatmentthroughlipidomics
AT martinapanini unveilingcellularchangesinleukaemiacelllinesaftercannabidioltreatmentthroughlipidomics
AT clarissacaroli unveilingcellularchangesinleukaemiacelllinesaftercannabidioltreatmentthroughlipidomics
AT matildemarani unveilingcellularchangesinleukaemiacelllinesaftercannabidioltreatmentthroughlipidomics
AT lorenzocorsi unveilingcellularchangesinleukaemiacelllinesaftercannabidioltreatmentthroughlipidomics
AT franciscojruperez unveilingcellularchangesinleukaemiacelllinesaftercannabidioltreatmentthroughlipidomics
AT antoniagarcia unveilingcellularchangesinleukaemiacelllinesaftercannabidioltreatmentthroughlipidomics
AT federicapellati unveilingcellularchangesinleukaemiacelllinesaftercannabidioltreatmentthroughlipidomics